Helping high-throughput laboratories increase multiplexing capacity and maximise sequencing throughput without changing established workflows
Read articleHelping high-throughput laboratories increase multiplexing capacity and maximise sequencing throughput without changing established workflows
ReadTransition programme begins with two IVDR-certified CytoCell® prenatal FISH probe kits designed to support rapid, standardised prenatal workflows.
ReadEnables ultra-low variant detection across a range of key MRD targets in AML, including very large FLT3-ITDs.
ReadOGT’s CytoCell KMT2A Breakapart FISH Probe Kit PDx detects clinically relevant rearrangements that occur in patients with acute leukaemia, providing a robust, accessible, rapid turnaround test for KMT2Ar detection.
ReadThrough this partnership, SureSeq™ NGS panel users can gain access to streamlined, high-confidence genomic insights and efficient, scalable reporting from sample to result.
ReadOGT will be moving from plastic packaging to new, sustainable packaging for CytoCell products, an important step forward in our ongoing environmental efforts.
ReadImproving upon existing SureSeq™ technology, this latest SureSeq NGS panel unlocks more efficient and expansive genetic profiling for CLL samples
ReadEnables users to replace multiple techniques with a single streamlined NGS process for faster results.
ReadInvestment in new premises to create increase in cutting-edge genomic solutions and collaborative partnerships.
ReadNew NGS assay delivers exceptional coverage, providing a rapid and highly sensitive means of investigating MRD in AML samples
ReadOGT becomes Britain’s distributor for ASI cytogenetic imaging and analysis solutions, enhancing the potential of OGT’s CytoCell® FISH portfolio.
ReadCompany demonstrates complete readiness for new EU IVDR and continued confidence in its safe, reliable, high-quality products.
Read
Visit USA site
Visit Canada site
